Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2013, Vol. 18 ›› Issue (4): 461-468.

Previous Articles     Next Articles

Effect of protein kinase C on cerebral ischemic reperfusion injury

ZHANG Feng-yun, ZHAO Yan, WU Yu-lin   

  1. Department of Physiology, China Pharmaceutical University, Nanjing 210009, Jiangsu, China
  • Received:2012-09-20 Online:2013-04-26 Published:2013-04-26

Abstract: Ischemic stroke is seriously hurting human health because of its high morbidity, disability rate and mortality. The pathophysiology mechanism is very complicated, which involves in expression exchanges of many genes and proteins (sensitive to apoptosis gene, Bcl-2 family proteins, glutathione perodxidase and heat shock protein). Only recombinant tissue plasminogen activator (rtPA) is currently being used in treatment of ischemic stroke by FDA. For multi-factors as inflammation and free radicals, contribute to ischemic stroke, however, many drugs, with few targets and significant side effects, cause a suboptimal therapeutic outcome. So developing new drugs in treatment of ischemic stroke will be an important issue. Some data demonstrated that PKC is likely to involve in mediating ischemic brain injury and may be a promising therapeutic target. Here the role of PKC and PKC isozymes in ischemic reperfusion injury will be discussed.

Key words: Ischemic stroke, PKC, Mechanism, Inflammation, Free radicals

CLC Number: